Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02194010 · ClinicalTrials.gov registry record

Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)

A clinical trial of Charcot Marie Tooth Disease and Inherited Peripheral Neuropathy, sponsored by University of Iowa.

Completed
Registry status
563
Enrollment target
3
Study locations

NCT02194010: Completed study of Charcot Marie Tooth Disease and Inherited Peripheral Neuropathy, sponsored by University of Iowa.

NCT02194010 is a study of Charcot Marie Tooth Disease and Inherited Peripheral Neuropathy that has completed, run by University of Iowa. The registered enrollment target is 563 participants, below the 2,285-participant average among 7 other Charcot Marie Tooth Disease trials with a reported enrollment target (75% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02194010, a study of Charcot Marie Tooth Disease and Inherited Peripheral Neuropathy, has completed, sponsored by University of Iowa.

COMPLETED
Registry status
563 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this research study is to create and validate two patient reported outcome (PRO) questionnaires. PRO questionnaires ask questions that help to measure disability in patients with inherited neuropathies. These questionnaires ask questions about what participants think disability is for themselves or others with inherited neuropathies. These questionnaires are a useful tool when evaluating whether treatments are working in the day to day life of an individual, although there are currently no questionnaires available specifically for people who have Charcot Marie Tooth disease (CMT).

Primary Outcome

The DSI asks the subject to provide information about how disability is reflected in general by equipment required for mobility. Therefore, the DSI asks the subject if a person in general was wearing AFOs (braces) for mobility, what level of disability would that reflect using both a quantitative measurement of score and a verbal method of scoring (none, mild, moderate, severe). These questions do not apply to the participant themselves, just in general how disabled they believe a person to be b

Study Locations (3)

Iowa

  • University of Iowa - Iowa City

New York

  • University of Rochester Medical Center - Rochester

Other

  • National Hospital of Neurology and Neurosurgery - London

Trial Details

FieldValue
Enrollment Target 563 participants
Start Date 2014-04
Est. Completion 2019-02
University of Iowa

228 total trials

What the finished NCT02194010 record still lists

NCT02194010 is an observational study that tracks outcomes without assigning an intervention. The registered 563 participants enrollment target is mid-sized for trials with a published cap, below the 2,285-participant average among 7 other Charcot Marie Tooth Disease trials with a reported enrollment target (75% lower).

The record links to 2 conditions, with Charcot Marie Tooth Disease appearing as the primary indexed condition, and to 0 interventions.

NCT02194010 reports a single indexed study location in Iowa, New York, Other.

Frequently Asked Questions

What is clinical trial NCT02194010 about?

NCT02194010 is a clinical study titled "Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)". The purpose of this research study is to create and validate two patient reported outcome (PRO) questionnaires. PRO questionnaires ask questions that help to measure disability in patients with inherited neuropathies. These questionnaires ask questions about what participants think disability is for...

What is the current status of trial NCT02194010?

This trial is currently completed. The enrollment target is 563 participants. The study started on 2014-04. Estimated completion is 2019-02.

What conditions does trial NCT02194010 study?

This clinical trial studies the following conditions: Charcot Marie Tooth Disease, Inherited Peripheral Neuropathy.

Who is sponsoring clinical trial NCT02194010?

This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02194010 being conducted?

This trial has 3 study locations across Iowa, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Charcot Marie Tooth Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06146725 · 564 participants

    The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

  • NCT06188520 · 564 participants · Phase 1

    A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors

  • NCT06628453 · 564 participants · NA

    CGM for Management of Type 2 Diabetes in Pregnancy

  • NCT07125326 · 564 participants · NA

    How the Method of Bladder Emptying After Epidural Placement in Labor Affects Postpartum Voiding

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02194010, the US trial registry maintained by the National Library of Medicine. NCT02194010 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.